High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.
Joe O'Sullivan, A.R. Norman, V.R. McCready, G. Flux, G. Cook, B. Johnson, J. Treleaven, D.P. Dearnaley
Research output: Contribution to journal › Article › peer-review